# Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide

> **NCT00717210** · PHASE3 · COMPLETED · sponsor: **Neuro-Oncology Working Group of the German Cancer Society** · enrollment: 318 (actual)

## Conditions studied

- Anaplastic Astrocytoma
- Oligodendroglioma
- Oligoastrocytoma

## Interventions

- **DRUG:** Temozolomide
- **RADIATION:** Focal radiotherapy

## Key facts

- **NCT ID:** NCT00717210
- **Lead sponsor:** Neuro-Oncology Working Group of the German Cancer Society
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-06
- **Primary completion:** 2005-02
- **Final completion:** 2008-03
- **Target enrollment:** 318 (ACTUAL)
- **Last updated:** 2008-07-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717210, "Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00717210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*